Outcomes Monitoring of Expanded Criteria Donor (ECD)/Donor after Cardiac Death (DCD) Organs in Liver Transplantation: A Region V Transplant Program Collaborative.

Slides:



Advertisements
Similar presentations
Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University
Advertisements

THE PATIENT’S JOURNEY TO TRANSPLANT AND BEYOND
SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.
Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
CMS Form 2728 ESRD Medical Evidence Report
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.
Impact of expanded criteria donors on patient survival after heart, lung, liver and combined organ transplantation Quebec experience from 2003 to 2009.
The Deceased Donor Kidney Allocation System
Why GIVE a Liver Transplant to Patients with GAVE Syndrome
Coordinator Training Session: March 11, 2012 Major Changes in Data EntryMyers 1 What is the same? What is reduced/removed? What is added/expanded? INTERMACS.
Living Donor Kidney Transplant April 15, 2012 Margaret Leid Transplant Community Liaison Penn Transplant Institute
Strategies for Maximizing Outcomes in Liver Transplantation James D. Eason, M.D. Chief of Transplantation / Professor of Surgery University of Tennessee.
Example of Medical Record Elements
+ Liver Transplantation for PSC Patients A Transplant Surgeon’s Perspective Tiffany Anthony, MD Annette C. and Harold C. Simmons Transplant Institute Baylor.
The New Kidney Allocation System Gautham Mogilishetty, MD Associate Professor of Medicine Division of Nephrology and Transplantation University of Cincinnati.
VCU Death and Complications Conference
Implementing pre-transplant performance review by the Membership and Professional Standards Committee Membership & Professional Standards Committee Fall.
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
Andreas A. Rostved, MD Research assistant Department of Surgical Gastroenterology and Transplantation Rigshospitalet – Copenhagen University Hospital Denmark.
LUNG TRANSPLANTATION Adult Recipients 2014 JHLT Oct; 33(10):
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
1 Simultaneous Liver-Kidney (SLK) Allocation Kidney Transplantation Committee Spring 2016.
Draft Organ Allocation Criteria. Factors affecting Allocation Medical need Length of waiting time: time a illness progressed to a point when transplant.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
소화기내과 김경엽 Gastroenterology 2011;140:
Jason P. Lott, Theodore J. Iwashyna, Jason D. Christie, David A. Asch, Andrew A. Kramer, and Jeremy M. Kahn Am J Respir Crit Care Med Vol 179. pp 676–683,
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
Organ Failure in Nepal: Rapidly Growing Challenge for All
Region 15 Regional Healthcare Partnership 4th Public Meeting
Clinical Change Forum 28th June, 2016
Dr. Iram Shad PGT-Medicine MU-1, HFH,RWP
Living Donor Transplants
LOMR Portal Project Chris Marsh MD, FACS, Project Lead
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
The Relationship between Postoperative Serum Albumin Level and Organ Dysfunction after Liver Transplantation. Results No differences were found between.
Liver Transplant Data for Regional Meetings
The Recipient Experience
UW Hospital and Clinics Organ Procurement Organization (OPO)
Number of transplants, by donor type figure 8.1
Nalaka Gunawansa, John McCall, Stephen Munn, Peter Johnston
P689 THE ROLE OF NUTRITIONAL ASSESSMENT FOR SIMULTANEOUS
Liver Transplantation: 50 years
Liver only transplants in the UK Question 2: In terms of survival benefit.
Feasibility Study) PB-PG
Stephen Sekoulopoulos and Dr. Jaimie Nathan
The Call is Made Rhonda Duggan, BSN, RN, CCTC August 29, 2014
Transplantation “the art of the do-over”
BRAZILIAN SINGLE CENTER SURVIVAL RATES AFTER LIVER
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
(1) Donor and Transplant Activity There has been an increase in the number of liver donors since 2007/08, with a concurrent mean 12% increase in.
Semiannual Report, March 2015
Addressing HLA Typing Errors
Liver Transplant Data for Regional Meetings
Liver and Intestinal Transplantation Committee
VCA Data Collection and Submission
Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD, MPH, FACC,
Introduction to Kidney Donor Risk Index (DRI)
Vascularized Composite Allograft (VCA) Transplantation Committee
Liver and Intestine Committee
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Vascularized Composite Allograft Transplantation Committee Fall 2014
Vascularized Composite Allograft (VCA) Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Liver Transplant Data for Regional Meetings
Vascularized Composite Allograft (VCA) Transplantation Committee
Liver Transplant Data for Regional Meetings
Donor Allocation Policy in the US
Liver Transplant Data for Regional Meetings
Multidisciplinary team approach to hepatocellular carcinoma management in a liver transplant center from Romania Cerban R.1, Iacob S.1, Croitoru A.1, Popescu.
Presentation transcript:

Outcomes Monitoring of Expanded Criteria Donor (ECD)/Donor after Cardiac Death (DCD) Organs in Liver Transplantation: A Region V Transplant Program Collaborative Dr Christopher L. Marsh Scripps Center for Organ Transplantation Scripps Green Hospital La Jolla, CA

Region V Participation Email Sent January 27th, 2016 General support for the concept of a Liver Outcomes Monitoring Registry (LOMR) Portal. A multi-program collaborative project involving 4-5 centers. Incorporates only liver candidate data and is voluntary. Data would be collected on post-transplant outcomes in ECD (including steatotic) and DCD candidates, but will need some SCDs. Defined data elements to be entered are detailed on slides 4 & 5. Post-transplant outcomes will be analyzed for outcomes, and those centers/sub-investigators participating would be authors on any report or manuscript generated from the use of the LOMR dataset. The only aspect of the study that will not be funded at this time is your centers time in entering these additional data elements into the LOMR Portal. Every effort will be made to use data already entered into UNet to minimize the date entry requirement.

Region V Participation Email January 27th, 2016 Cont’d Still several framework decisions to be decided and this will be part of the initial discussions for the LOMR Advisory Group. These include but are not limited to:- The optimal number of candidates to include, The duration of the study, If additional sites can be rolled in over time.

Region V Liver Outcome Monitoring Registry (LOMR) Portal Overview •Identify defined data elements •Develop LOMR Operational Guidelines •Encourage site participation Region V LOMR Advisory Group OPTN Site Data Data •System hosting & support (i.e. LOMR Portal) Data collection System Administrator (UNOS) •LOMR participants to get a dataset of their own patient-identifiable data •LOMR participants have access to the complete (all participants) de-identified dataset Data distribution Data Sharing

Adult Recipients of Deceased Donor Liver Transplants, All Programs in Region 5 July 1, 2015 - December 31, 2015 Donor Type Variable N Min 25th Pctl Median 75th Max DCD DRI %Micro fat %Macro fat 23 2 4 1.5 5.0 0.0 1.8 5.0 0.0 1.9 7.5 2.5 2.3 10.0 5.0 2.4 10.0 5.0 ECD 104 50 54 1.3 0.0 0.0 1.7 0.0 0.0 1.8 5.0 5.0 2.0 10.0 10.0 2.4 70.0 40.0 SCD 302 74 79 0.8 0.0 0.0 1.1 0.0 0.0 1.3 5.0 5.0 1.5 10.0 20.0 2.2 90.0 80.0

Adult Recipients of Deceased Donor Liver Transplants, Potential Participants in Region 5 July 1, 2015 - December 31, 2015 Tx Center ECD/DCD/SDC Total DCD ECD SCD N % AZMC: Mayo Clinic Hospital 7 19.4 10 27.8 19 52.8 36 CAGH: Scripps Green Hospital 4 33.3 8 66.7 12 CAPM: California Pacific Medical Ctr 1 2.6 16 41.0 22 56.4 39 CASF: Univ of California San Francisco Medical Ctr 6 9.7 18 29.0 38 61.3 62 CAUC: Univ of California at Los Angeles Medical Ctr 1.5 14 21.5 50 76.9 65 15 7.0 137 64.0 214

Adult Recipients of Deceased Donor Liver Transplants, Potential Participants in Region 5 July 1, 2015 - December 31, 2015 Tx Center Macro Fat > 20% Micro Fat > 20% DRI > 1.8 N % AZMC: Mayo Clinic Hospital 3 8.3 1 2.8 15 41.7 CAGH: Scripps Green Hospital 2 16.7 25.0 CAPM: California Pacific Medical Ctr 7.7 4 10.3 9 23.1 CASF: Univ of California San Francisco Medical Ctr 1.6 21 33.9 CAUC: Univ of California at Los Angeles Medical Ctr 1.5 12 18.5 Total 10 4.7 5 2.3 60 28.0

LOMR Portal Data Elements OPTN? Form Field/Description/Notes Demographics Recipient Identification Number Yes TRR TRR_ID UNOS Donor ID #* DON_ID Date of Birth* TCR DOB Gender* GENDER Ethnicity/ Race TCR/Calculated ETHCAT Highest Education Level* EDUCATION Employment status* WORK_INCOME Surgical Profile Recipient had a Prior Transplant Procedure Calculated Based on OPTN Data Recipient Height* HGT_CM Recipient Weight* WGT_KG Recipient BMI (calculated) Calculated from height and weight Recipient Diabetes Mellitus DIAB Recipient Hypertension No N/ Current Smoker within One Year Functional Health Status* FUNC_STAT Recipient Recent Infection Patient on Dialysis at Time of Transplant Yes/No WL Collect on waiting list creatinine or yes/no dialysis twice within prior week for MELD calculation Pre-Operative Labs Recipient Blood Type* ABO Recipient Preoperative Lab Value Information (WBC, Cr. AST, ALT, Bili, INR) Yes and No Collect Creatinine, Bilirubin, and INR for MELD calculation Recipient Medical Condition* MED_COND Primary Diagnosis* TCR and TRR Primary and Secondary on TCR, TRR pre-transplant and pathology confirmed Listing Status: Status 1, exception Waiting list information Match Meld UNOS_CAND_STAT_CD Recipient Portal Vein Thrombosis describe Yes/No Field Only Recipient intubated at time of transplant Recipient Cancer * Previous Malignancy at Listing, if yes collect type Recipient Hepatocellular Carcinoma (HCC) Ever diagnosed with HCC on TRR, new field Recipient Transjugular Intrahepatic Portosystemic Shunt (TIPS)? Recipient Prior Abdominal Surgery- verify with living At listing and at transplant History of Spontaneous Bacterial Peritonitis (SBP) ?? Not any history, yes/no at time of listing, not at transplant Recipient MELD Labs Lab values used to calculate MELD Operative Information Date of Procedure* TX_DATE

LOMR Portal Data Elements Cont’d Cold Ischemia Time- calculated Yes TRR Cold Ischemic Time Multi-organ Transplant Calculated Use other OPTN data to calculated Graft Type: split, whole, Living donor Procedure type Biliary Stent Present at Transplant Biliary Anastomosis Portal Vein Reconstruction/Graft Type Hepatic Artery Reconstruction/Bypass Recipient Post-operative Outcomes (collected at 30 days) PRBC Units (0 to 72 hours post-op) No Length of Initial Hospital Stay Discharge Date and Admission Date on TRR Total number of Post-Procedural ICU days N/ On Ventilator > 48 Hours N/ Intraoperative or Postoperative Cardiac Arrest Requiring CPR Portal Vein Thrombosis/Stenosis requiring Therapy Hepatic Artery Stenosis/Thrombosis requiring Therapy Biliary Stricture requiring Intervention Biliary Leak requiring Intervention Graft Loss TRR/TRF Calculated from most recent follow-up information with date Discharge Tab Hospital Readmission Return to the OR Death Patient Follow-up at 90 Days Biliary Stricture requiring intervention Initiation of postoperative dialysis (within POD 31-90 days) need intent, definition/ criteria Reoperation First Follow-up at Six Months Re Intervention-performed IR, procedural room Patient Follow-up at 1 Year Primary Reason for Graft Loss Yes/No Collect all contributing causes of graft failure. Don't collect a primary cause of failure. Re Intervention-performed IR, procedural room Include CPT code No Hospital Readmission Yes/No TRF Collect readmission at six months and one year, if yes on either then yes readmission within one year.